Xoma Royalty Share Price Today
(NASDAQ: XOMA)

Name: Xoma Royalty Share Price Today (NASDAQ: XOMA) - Xoma Royalty Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Xoma Royalty share price is $24.88 & ₹2,167.05 as on 4 Feb 2025, 2.30 'hrs' IST

$24.88

▲

-1.73

(-6.5%)

Market is closed - opens 8 PM, 04 Feb 2025

View live Xoma Royalty share price in Dollar and Rupees. Guide to invest in Xoma Royalty stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Xoma Royalty, along with analyst recommendations, forecasts, and comprehensive financials.

Xoma Royalty share price movements

Today's Low: $24.86
Today's High: $26.07
$24.88
0.08%
Downside
Day's Volatility :4.64%
Upside
4.56%
52 Weeks Low: $19.50
52 Weeks High: $35.00
$24.88
21.62%
Downside
52 Weeks Volatility :44.29%
Upside
28.91%

Xoma Royalty (XOMA) Returns

Period	Xoma Royalty Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-19.79%	0.5%	0.0%
6 Months	6.19%	-2.3%	0.0%
1 Year	24.15%	3.8%	0.0%
3 Years	23.97%	11.4%	-11.7%

Xoma Royalty (XOMA) Key Statistics

in dollars & INR

Previous Close	$26.61
Open	$26.13
Today's High	$26.07
Today's Low	$24.8608
Market Capitalization	$313.5M
Today's Volume	$47.7K
52 Week High	$35.0
52 Week Low	$19.5
Revenue TTM	$21.6M
EBITDA	$-15.2M
Earnings Per Share (EPS)	$-3.07
Profit Margin	-138.67%
Quarterly Earnings Growth YOY	0.37%
Return On Equity TTM	-31.41%

How to invest in Xoma Royalty Stock (XOMA) from India?

It is very easy for Indian residents to invest directly in Xoma Royalty from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xoma Royalty stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xoma Royalty or XOMA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xoma Royalty or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xoma Royalty shares which would translate to 0.035 fractional shares of Xoma Royalty as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Xoma Royalty, in just a few clicks!

Returns in Xoma Royalty (XOMA) for Indian investors in Rupees

The Xoma Royalty stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Xoma Royalty investment value today

Current value as on today

₹1,29,022

Returns

₹29,022

(+29.02%)

Returns from Xoma Royalty Stock

₹24,152 (+24.15%)

Dollar Returns

₹4,871 (+4.87%)

Indian investors sentiment towards Xoma Royalty (XOMA)

300%

Period: Jan 4, 2025 to Feb 3, 2025. Change in 30 Days versus previous period

Search interest for Xoma Royalty Stock from India on INDmoney has increased by 300% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Xoma Royalty

Bvf Inc
30.84%
FMR Inc
9.36%
BlackRock Inc
4.55%
Vanguard Group Inc
3.58%
Opaleye Management Inc
2.12%
Stonepine Capital Management Llc
1.66%

Analyst Recommendation on Xoma Royalty

Buy

77%Buy

22%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Xoma Royalty(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Xoma Royalty Stock (XOMA)

What analysts predicted

Upside of 257.72%

Target:

$89.00

Current:

$24.88

Insights on Xoma Royalty Stock (Ticker Symbol: XOMA)

Price Movement
In the last 7 days, XOMA stock has moved down by -6.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 11.08M → 7.19M (in $), with an average decrease of 35.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 15.98M → -17.24M (in $), with an average decrease of 207.9% per quarter
XOMA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.6% return, outperforming this stock by 35.4%
XOMA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 88.8% return, outperforming this stock by 66.1%
Price to Sales
ForXOMA every $1 of sales, investors are willing to pay $13.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.6 for every $1 of sales.

XOMA Xoma Royalty Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$5.3M	↓ 89.94%
Net Income	$-13.3M	↓ 191.42%
Net Profit Margin	-251.8%	↓ 279.5%

	FY19	Y/Y Change
Revenue	$18.4M	↑ 246.67%
Net Income	$-7.7M	↓ 42.31%
Net Profit Margin	-41.91%	↑ 209.89%

	FY20	Y/Y Change
Revenue	$29.4M	↑ 59.96%
Net Income	$13.3M	↓ 272.75%
Net Profit Margin	45.25%	↑ 87.16%

	FY21	Y/Y Change
Revenue	$38.2M	↑ 29.86%
Net Income	$15.8M	↑ 18.8%
Net Profit Margin	41.4%	↓ 3.85%

	FY22	Y/Y Change
Revenue	$6.0M	↓ 84.21%
Net Income	$-17.1M	↓ 208.27%
Net Profit Margin	-283.79%	↓ 325.19%

	FY23	Y/Y Change
Revenue	$4.8M	↓ 21.06%
Net Income	$-40.8M	↑ 138.72%
Net Profit Margin	-858.15%	↓ 574.36%

	Q2 FY23	Q/Q Change
Revenue	$1.7M	↑ 279.41%
Net Income	$-5.4M	↓ 69.53%
Net Profit Margin	-325.69%	↑ 3729.23%

	Q3 FY23	Q/Q Change
Revenue	$830.0K	↓ 49.94%
Net Income	$-5.5M	↑ 2.02%
Net Profit Margin	-663.73%	↓ 338.04%

	Q4 FY23	Q/Q Change
Revenue	$1.8M	↑ 120.84%
Net Income	$-20.1M	↑ 265.02%
Net Profit Margin	-1.1K%	↓ 433.32%

	Q1 FY24	Q/Q Change
Revenue	$1.5M	↓ 18.71%
Net Income	$-8.6M	↓ 57.26%
Net Profit Margin	-576.85%	↑ 520.2%

	Q2 FY24	Q/Q Change
Revenue	$11.1M	↑ 644.03%
Net Income	$16.0M	↓ 285.98%
Net Profit Margin	144.19%	↑ 721.04%

	Q3 FY24	Q/Q Change
Revenue	$7.2M	↓ 35.08%
Net Income	$-17.2M	↓ 207.87%
Net Profit Margin	-239.59%	↓ 383.78%

	FY18	Y/Y Change
Profit	$3.6M	↓ 91.93%

	FY19	Y/Y Change
Profit	$17.1M	↑ 373.24%

	FY20	Y/Y Change
Profit	$29.2M	↑ 70.68%

	FY21	Y/Y Change
Profit	$38.0M	↑ 30.03%

	FY22	Y/Y Change
Profit	$5.9M	↓ 84.39%

	FY23	Y/Y Change
Profit	$3.9M	↓ 34.89%

	Q2 FY23	Q/Q Change
Profit	$1.4M	↑ 576.42%

	Q3 FY23	Q/Q Change
Profit	$606.0K	↓ 57.74%

	Q4 FY23	Q/Q Change
Profit	$1.6M	↑ 165.35%

	Q1 FY24	Q/Q Change
Profit	$1.5M	↓ 7.46%

	Q2 FY24	Q/Q Change
Profit	$11.1M	↑ 644.83%

	Q3 FY24	Q/Q Change
Profit	$7.2M	↓ 35.06%

	FY18	Y/Y Change
Operating Cash Flow	$-12.6M	↓ 570.74%
Investing Cash Flow	$-15.0M	↓ 1034.37%
Financing Cash Flow	$29.9M	↑ 125.82%

	FY19	Y/Y Change
Operating Cash Flow	$-285.0K	↓ 97.75%
Investing Cash Flow	$-19.3M	↑ 28.62%
Financing Cash Flow	$30.5M	↑ 1.85%

	FY20	Y/Y Change
Operating Cash Flow	$10.1M	↓ 3641.05%
Investing Cash Flow	$-209.0K	↓ 98.92%
Financing Cash Flow	$19.8M	↓ 35.09%

	FY21	Y/Y Change
Operating Cash Flow	$22.7M	↑ 124.71%
Investing Cash Flow	$-26.5M	↑ 12579.43%
Financing Cash Flow	$12.8M	↓ 35.15%

	FY22	Y/Y Change
Operating Cash Flow	$-12.9M	↓ 156.79%
Investing Cash Flow	$-20.2M	↓ 23.69%
Financing Cash Flow	$-4.5M	↓ 134.68%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-7.2M	↑ 46.39%
Investing Cash Flow	$-4.5M	↓ 38.04%
Financing Cash Flow	$-1.2M	↓ 14.84%

Xoma Royalty Technicals Summary

Sell

Neutral

Buy

Xoma Royalty is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Xoma Royalty (XOMA) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Xoma Royalty Corp	-5.29%	6.19%	24.15%	23.97%	-1.62%
Biontech Se	-0.32%	50.72%	28.36%	-30.66%	263.86%
Regeneron Pharmaceuticals, Inc.	-6.9%	-37.45%	-28.78%	7.15%	71.05%
Vertex Pharmaceuticals Incorporated	16.87%	-0.83%	9.67%	93.36%	96.71%
Alnylam Pharmaceuticals, Inc.	17.76%	4.57%	60.84%	84.7%	125.11%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Xoma Royalty Corp	24.2	NA	-0.42	-1.13	-0.31	-0.06	NA	7.21
Biontech Se	160.8	NA	0.04	-3.32	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.64	16.64	1.08	44.92	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.49	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Xoma Royalty Corp	Buy	$313.5M	-1.62%	24.2	-138.67%
Biontech Se	Buy	$29.7B	263.86%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$74.0B	71.05%	16.64	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$118.9B	96.71%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.0B	125.11%	NA	-15.86%

About Xoma Royalty

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Organization	Xoma Royalty
Employees	13
CEO	Mr. Owen P. Hughes Jr.
Industry	Health Technology

Management People of Xoma Royalty

Name	Title
Mr. Owen P. Hughes Jr.	CEO & Director
Mr. Thomas M. Burns	Senior VP of Finance & CFO
Mr. Brad Sitko	Chief Investment Officer

Important FAQs about investing in XOMA Stock from India :

What is Xoma Royalty share price today?

Xoma Royalty share price today stands at $24.88, Open: $26.13 ; Previous Close: $26.61 ; High: $26.07 ; Low: $24.86 ; 52 Week High: $35.00 ; 52 Week Low: $19.50.

The stock opens at $26.13, after a previous close of $26.61. The stock reached a daily high of $26.07 and a low of $24.86, with a 52-week high of $35.00 and a 52-week low of $19.50.

Can Indians buy Xoma Royalty shares?

Yes, Indians can invest in the Xoma Royalty (XOMA) from India.

With INDmoney, you can buy Xoma Royalty at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Xoma Royalty at zero transaction cost.

How can I buy Xoma Royalty shares from India?

It is very easy to buy Xoma Royalty from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xoma Royalty (XOMA) be purchased?

Yes, you can buy fractional shares of Xoma Royalty with INDmoney app.

What are the documents required to start investing in Xoma Royalty stocks?

To start investing in Xoma Royalty, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.